Cartesian Therapeutics (RNAC) Goodwill (2023 - 2025)
Historic Goodwill for Cartesian Therapeutics (RNAC) over the last 3 years, with Q3 2025 value amounting to $48.2 million.
- Cartesian Therapeutics' Goodwill changed 0.0% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $48.2 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, Cartesian Therapeutics' Goodwill is $48.2 million, which was down 0.0% from $48.2 million recorded in Q2 2025.
- Over the past 5 years, Cartesian Therapeutics' Goodwill peaked at $48.2 million during Q4 2023, and registered a low of $48.2 million during Q4 2023.
- Over the past 3 years, Cartesian Therapeutics' median Goodwill value was $48.2 million (recorded in 2023), while the average stood at $48.2 million.
- Data for Cartesian Therapeutics' Goodwill shows a peak YoY increase of 0.0% (in 2024) and a maximum YoY decrease of 0.0% (in 2024) over the last 5 years.
- Over the past 3 years, Cartesian Therapeutics' Goodwill (Quarter) stood at $48.2 million in 2023, then changed by 0.0% to $48.2 million in 2024, then changed by 0.0% to $48.2 million in 2025.
- Its last three reported values are $48.2 million in Q3 2025, $48.2 million for Q2 2025, and $48.2 million during Q1 2025.